Browsing Tag
Bioniz Therapeutics
3 posts
Equillium acquires Bioniz Therapeutics to expand immunomodulatory drug pipeline
Equillium, a Nasdaq-listed biotech company, has acquired Bioniz Therapeutics in a deal worth up to around $329 million,…
Bioniz Therapeutics gets EC orphan drug status for BNZ-1 for CTCL
Bioniz Therapeutics has secured orphan drug designation for BNZ-1 from the European Commission (EC) for the treatment of…
Bioniz Therapeutics reports positive phase 1/2 trial data for BNZ-1 in treating relapsed/refractory CTCL
Bioniz Therapeutics, a leading player in the field of peptide-based therapeutics, has revealed promising data from a phase…